A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer
-
Published:2021-02-01
Issue:1
Volume:13
Page:
-
ISSN:1756-994X
-
Container-title:Genome Medicine
-
language:en
-
Short-container-title:Genome Med
Author:
López de Maturana Evangelina, , Rodríguez Juan Antonio, Alonso Lola, Lao Oscar, Molina-Montes Esther, Martín-Antoniano Isabel Adoración, Gómez-Rubio Paulina, Lawlor Rita, Carrato Alfredo, Hidalgo Manuel, Iglesias Mar, Molero Xavier, Löhr Matthias, Michalski Christopher, Perea José, O’Rorke Michael, Barberà Victor Manuel, Tardón Adonina, Farré Antoni, Muñoz-Bellvís Luís, Crnogorac-Jurcevic Tanja, Domínguez-Muñoz Enrique, Gress Thomas, Greenhalf William, Sharp Linda, Arnes Luís, Cecchini Lluís, Balsells Joaquim, Costello Eithne, Ilzarbe Lucas, Kleeff Jörg, Kong Bo, Márquez Mirari, Mora Josefina, O’Driscoll Damian, Scarpa Aldo, Ye Weimin, Yu Jingru, García-Closas Montserrat, Kogevinas Manolis, Rothman Nathaniel, Silverman Debra T, Albanes Demetrius, Arslan Alan A, Beane-Freeman Laura, Bracci Paige M, Brennan Paul, Bueno-de-Mesquita Bas, Buring Julie, Canzian Federico, Du Margaret, Gallinger Steve, Gaziano J Michael, Goodman Phyllis J, Gunter Marc, LeMarchand Loic, Li Donghui, Neale Rachael E, Peters Ulrika, Petersen Gloria M, Risch Harvey A, Sánchez Maria José, Shu Xiao-Ou, Thornquist Mark D, Visvanathan Kala, Zheng Wei, Chanock Stephen J, Easton Douglas, Wolpin Brian M, Stolzenberg-Solomon Rachael Z, Klein Alison P, Amundadottir Laufey T, Marti-Renom Marc A, Real Francisco X, Malats NúriaORCID,
Abstract
Abstract
Background
Pancreatic cancer (PC) is a complex disease in which both non-genetic and genetic factors interplay. To date, 40 GWAS hits have been associated with PC risk in individuals of European descent, explaining 4.1% of the phenotypic variance.
Methods
We complemented a new conventional PC GWAS (1D) with genome spatial autocorrelation analysis (2D) permitting to prioritize low frequency variants not detected by GWAS. These were further expanded via Hi-C map (3D) interactions to gain additional insight into the inherited basis of PC. In silico functional analysis of public genomic information allowed prioritization of potentially relevant candidate variants.
Results
We identified several new variants located in genes for which there is experimental evidence of their implication in the biology and function of pancreatic acinar cells. Among them is a novel independent variant in NR5A2 (rs3790840) with a meta-analysis p value = 5.91E−06 in 1D approach and a Local Moran’s Index (LMI) = 7.76 in 2D approach. We also identified a multi-hit region in CASC8—a lncRNA associated with pancreatic carcinogenesis—with a lowest p value = 6.91E−05. Importantly, two new PC loci were identified both by 2D and 3D approaches: SIAH3 (LMI = 18.24), CTRB2/BCAR1 (LMI = 6.03), in addition to a chromatin interacting region in XBP1—a major regulator of the ER stress and unfolded protein responses in acinar cells—identified by 3D; all of them with a strong in silico functional support.
Conclusions
This multi-step strategy, combined with an in-depth in silico functional analysis, offers a comprehensive approach to advance the study of PC genetic susceptibility and could be applied to other diseases.
Funder
Instituto de Salud Carlos III Fundación Científica Asociación Española Contra el Cáncer EU H2020 COST EU-6FP Integrated Project EU-FP7-HEALTH Associazione Angela Serra per la Ricerca sul Cancro Cancer Focus Northern Ireland and Department for Employment and Learning ALF Lustgarten Foundation & Stand-Up to Cancer Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine
Reference86 articles.
1. Carrato A, Falcone A, Ducreux M, Valle JW, Parnaby A, Djazouli K, et al. A systematic review of the burden of pancreatic cancer in Europe: real-world impact on survival, quality of life and costs. J Gastrointest Cancer. 2015;46:201–11. 2. Malvezzi M, Bertuccio P, Rosso T, Rota M, Levi F, La Vecchia C, et al. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? Ann Oncol. 2015;26:779–86. 3. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends - an update. Cancer Epidemiol Biomark Prev. 2016;25:16–27. 4. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–21. 5. Buniello A, Macarthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47:D1005–12.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|